Therapeutic banner
Therapeutic banner

Acute Hepatic Porphyria (AHP)

View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to AHP.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.

Explore Therapeutic Areas

Publications

View More Arrow

Acute Hepatic Porphyria (AHP)

Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study

Orphanet Journal of Rare Diseases

Author(s)

Bruce Wang, Paolo Ventura, Kei-Ichiro Takase, et al

August 2022

Acute Hepatic Porphyria (AHP)

Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts

Advances in Therapy

Author(s)

Kristen Wheeden, Desiree Lyon Howe, Sue Burrell, et al

July 2022

Acute Hepatic Porphyria (AHP)

A Drug-Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver

Clinical Pharmacology and Therapeutics

Author(s)

Daphne Vassiliou, Eliane Sardh, Pauline Harper, et al

September 2021

Acute Hepatic Porphyria (AHP)

Normal reference ranges for urinary δ-aminolevulinic acid and porphobilinogen levels

JIMD Reports

Author(s)

Sagar Agarwal, Bahru Habtemarium, Yuanxin Xu, et al

October 2020

Acute Hepatic Porphyria (AHP)

Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria

PLOS One

Author(s)

Aaron M Cohen, Steven Chamberlin, Thomas Deloughery, et al

July 2020

Acute Hepatic Porphyria (AHP)

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

New England Journal of Medicine

Author(s)

Manisha Balwani, Eliane Sardh, Paolo Ventura, et al

June 2020